Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9 |
High Similarity |
NPD1510 |
Phase 2 |
0.8944 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8723 |
High Similarity |
NPD1607 |
Approved |
0.8714 |
High Similarity |
NPD1240 |
Approved |
0.8601 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8552 |
High Similarity |
NPD1549 |
Phase 2 |
0.8497 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8483 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8483 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8456 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8456 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8435 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8354 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8301 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8288 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8278 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8258 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8258 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8153 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8121 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8089 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8085 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8041 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8013 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7973 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7959 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7945 |
Intermediate Similarity |
NPD943 |
Approved |
0.7919 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7883 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD920 |
Approved |
0.7862 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7792 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7791 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5494 |
Approved |
0.777 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7763 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7748 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7748 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7682 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7665 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7607 |
Intermediate Similarity |
NPD919 |
Approved |
0.7593 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD9717 |
Approved |
0.75 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5405 |
Approved |
0.745 |
Intermediate Similarity |
NPD411 |
Approved |
0.745 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7425 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7417 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7394 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7372 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD3764 |
Approved |
0.733 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD37 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD7003 |
Approved |
0.726 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7253 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD4749 |
Approved |
0.72 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7168 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7128 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7103 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7072 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7072 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7033 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7011 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6986 |
Remote Similarity |
NPD5691 |
Approved |
0.6984 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD6535 |
Approved |
0.6978 |
Remote Similarity |
NPD6534 |
Approved |
0.6974 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6968
|
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |